期刊文献+

糖尿病患者凝血状态及影响因素研究 被引量:9

Blood coagulation and its influcing factors in diabetes mellitus patients
下载PDF
导出
摘要 目的观察糖尿病患者与非糖尿病患者的凝血状态差异及其影响因素,为临床治疗糖尿病合并凝血功能异常提供参考。方法选择糖尿病患者251例(糖尿病组),糖尿病组又根据是否有大血管病变分为大血管病变组163例,无大血管病变组88例,另选择健康体检者80例(对照组),观察其凝血酶时间(TT)、活化部分凝血酶原时间(APTT)、凝血酶原时间(PT)、纤维蛋白原(Fib)的差异。结果糖尿病组TT[(16.28±1.44)s vs(17.80±0.97)s]、APTT[(35.57±3.73)s vs(37.46±4.17)s]、PT[(12.60±1.08)s vs(13.84±0.60)s]较对照组明显缩短,Fib[(3.21±0.87)g/L vs(2.91±0.55)g/L]较对照组明显增高(P<0.05,P<0.01)。大血管病变组Fib较无大血管病变组明显升高(P=0.03)。糖尿病组主要影响凝血指标的是糖化血红蛋白、TC、LDL-C。结论糖尿病患者存在凝血系统的异常,糖化血红蛋白、TC、LDL-C水平与凝血指标具有明显的相关性。 Objective To study the blood coagulation and its influencing factors in diabetes mellitus(DM)patients and non-DM patients.Methods Two hundred and fifty-one DM patients served as a DM group and were further divided into great vessel lesion group(n=163)and non-great vessel lesion group(n=88).Eighty subjects undergoing physical examination served as a control group.Their TT,APTT,and PT were recorded and their serum Fib level was measured.Results The TT,APTT,and PT were significantly shorter and the serum Fib level was significantly higher in DM group than in control group(16.28±1.44svs17.80±0.97 s,35.57±3.73svs37.46±4.17 s,12.60±1.08 svs 13.84±0.60 s,3.21±0.87g/L vs 2.91±0.55g/L,P〈0.05,P〈0.01).The serum levels of HbA1 c,TC and LDL-C were the major influencing factors for blood coagulation in DM patients.Great vessel lesion was related with the elevated serum Fib level.Conclusion The abnormal blood coagulation is closely related with the serum levels of HbA1 c,TC,and LDL-C in DM patients.
出处 《中华老年心脑血管病杂志》 CAS 2015年第5期485-487,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
基金 军队保健专项课题(11BJZ10)
关键词 糖尿病 血液凝固 凝血酶时间 凝血酶原时间 纤维蛋白原 胆固醇 LDL diabetes mellitus blood coagulation thrombin time prothrombin time fibrinogen cho-lesterol, LDL
  • 相关文献

参考文献10

  • 1Mishiro K,Imai T,Sugitani S,et al.Diabetes mellitus aggravates hemorrhagic transformation after ischemic stroke via mitochondrial defects leading to endothelial apoptosis.PLoS One,2014,9:e103818.
  • 2Hgg S,Thom LM,Forsblom CM,et al.Different risk factor profiles for ischemic and hemorrhagic stroke in type 1diabetes mellitus.Stroke,2014,45:2558-2562.
  • 3Mendivil CO,Robles-Osorio L,Horton ES,et al.Young Hispanics at risk of type 2diabetes display endothelial activation,subclinical inflammation and alterations of coagulation and fibrinolysis.Diabetol Metab Syndr,2013,5:371-378.
  • 4Kim HK,Kim JE,Park SH,et al.High coagulation factor levels and low protein C levels contribute to enhanced thrombin generation in patients with diabetes who do not have macrovascular complications.J Diebetes Complications,2014,28:365-369.
  • 5Nemmar A,Subramaniyan D,Yasin J,et al.Impact of experimental type 1diabetes mellitus on systemic and coagulation vulnerably in mice acutely exposed to diesel exhaust particles.Part Fibre Toxicol,2013,10:141-148.
  • 6Khan S,Khan S,Imran M,et al.Effects of pioglitazone and vildagliptin on coagulation cascade in diabetes mellitus--targeting thrombogenesis.Expert Opin Ther Targets,2013,17:627-639.
  • 7Yang KS,Lim JH,Kim TW,et al.Vascular endothelial growth factor-receptor 1inhibition aggravates diabetic nephropathy through eNOS signaling pathway in db/db mice.PLoS One,2014,9:e94540.
  • 8Lippi G,Franchini M,Targher G,et al.Epidemiological association between fasting plasma glucose and shortened APTT.Clin Bilchem,2009,42:118-120.
  • 9Sapkota B,Shrestha SK,Poudel S.Association of activated partial thromboplastin time and fibrinogen level in patients with typeⅡdiabetes mellitus.BMC Res Notes,2013,6:485.
  • 10Bembde AS.A study of plasma fibrinogen level in type-2diabetes mellitus and its relation to glycemic control.Indian J Hematol Blood Transfus,2012,28:105-108.

同被引文献94

  • 1中华医学会内分泌学分会.中国成人2型糖尿病预防的专家共识[J].中华内分泌代谢杂志,2014,30(4). 被引量:163
  • 2《中国糖尿病防治指南》(试行本)(节选)[J].中国慢性病预防与控制,2004,12(6):283-285. 被引量:304
  • 3邹海东,张皙,朱剑锋,汪枫桦,许迅,王伟伟,吴美芳.上海市北新泾街道糖尿病患者视网膜病变的患病率调查[J].中华眼底病杂志,2006,22(1):31-34. 被引量:82
  • 4Cart ME. Diabetes mellitus: hypercoagulable state [ J ]. Diabetes Complication,2001,15:44 - 54.
  • 5Sakkinen P, Wahl P, Cushman M, et al. Clustering of procoagula- tion,inflammation and fibrinolysis variables with metabolic factors in insulin resistance syndrome [ J ]. Am J Epidemiol, 2000,152 : 897 - 907.
  • 6Unwin N, Gan D, Whiting D. The IDF Diabetes Atlas:providing evidence, raising awareness and promoting action [ J ]. Diabetes Res Clin Pr,2010,87-2 -3.
  • 7Park K, Chen Y, Hu Y,et al. Nanoparticle-medicted expression of an angiogenic inhibitor ameliorates ischemia-induced retinal neo- vaseularization and diabetes induced detinal vascular leakage [ J]. Diabetes ,2009,58 : 1902 - 1913.
  • 8《中国2型糖尿病防治指南》编写组.中国2型糖尿病防治指南(2010年版)[M].北京:北京大学医学出版社,2010:6-8.
  • 901a MS,Nawaz MI,Siddiquei MM,et al. Recent adwances in un- derstanding the biochemical and molecular nechanism of diabetic retinopathy[ J]. J Diabetes Complications,2012,26( 1 ) :56 - 64.
  • 10Imperatore G, Riccardi G, Iovine C, et al. Plasma fibrinogen : a new factor of the metabolic syndrome : a population-based study [J]. Diabetes Care,1998,21:649 -654.

引证文献9

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部